Clinical Trial

Depression Among Cardiothoracic Surgery Patients in Baghdad

Study acronym: PHQ-9
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to estimate the prevalence and severity of depression among patients in the Cardiothoracic Surgery Ward in Baghdad City, Iraq, using a self-administered PHQ-9 questionnaire. The main questions it aims to answer are: What is the prevalence of depression among cardiothoracic surgery patients? How is the severity of depression distributed within this group? Are there specific environmental or demographic factors associated with higher levels of depression? Participants will: Fill out the PHQ-9 in order to measure the severity of depressive symptoms at a specific moment in time. Demographic and clinical variables such as age, gender, socioeconomic status, surgery type, comorbidities, and hospital stay length should be taken to look for a possible relationship with depression.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-12-12; most recent amendment 2025-03-16.
Trial Details
NCT Number NCT06734169
Lead Sponsor Al-Nahrain University
Conditions Depression
Enrollment 200 participants
Start Date 2025-04-20
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-06-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-18